Company page
Eupraxia Pharmaceuticals, Inc.
Eupraxia Pharmaceuticals, Inc. is a public company traded on the Canadian market under the ticker EPRX. The company has a market capitalization of approximately CAD 403.56 million. Eupraxia focuses on developing innovative pharmaceutical solutions to address unmet medical needs.
- Ticker
- EPRX:TSX
- Asset type
- Stock
- Market cap
- $403.6M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TSX
- Currency
- CAD